LataMed AI Corp. (OTC: LMED), a digital health and artificial intelligence technology company focused on emerging markets, announced it has begun operational, technical, and commercial evaluations to potentially integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later financial technology platform in Venezuela. The initiative aims to reduce upfront financial barriers for patients seeking access to private healthcare services, consultations, diagnostics, wellness programs, and other eligible offerings within the LataMed AI ecosystem.
Management believes that improving payment accessibility may support greater patient engagement, increased healthcare utilization, stronger platform adoption, and broader access to private healthcare services. By addressing affordability challenges, the company expects to strengthen its position as a technology-enabled healthcare marketplace serving patients, providers, and partners throughout Latin America. The potential integration aligns with LataMed AI's broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a more scalable healthcare marketplace.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI, stated: "We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem. We believe initiatives such as this have the potential to strengthen patient acquisition, improve engagement, and support long-term platform growth."
For leaders in business and technology, this development highlights the growing convergence of fintech and healthcare in emerging markets. By leveraging Cashea's buy-now-pay-later model, LataMed AI could tap into a broader patient base that otherwise might forgo private care due to cost constraints. This approach mirrors trends in other regions where installment payments have improved access to services and boosted platform adoption. If successful, the integration could serve as a blueprint for other digital health companies seeking to overcome affordability hurdles in price-sensitive markets.
The company has not yet entered a definitive commercial agreement, and completion of any integration remains subject to further discussions, technical implementation, regulatory review, and customary business conditions. LataMed AI intends to provide updates as material developments occur. For additional information, visit https://latamed.ai or review SEC filings at www.sec.gov.
This strategic evaluation underscores the importance of payment innovation in healthcare. As private healthcare costs rise, the ability to offer flexible payment options could become a competitive differentiator for digital health platforms. For LataMed AI, which focuses on Latin America—a region with significant uninsured and underinsured populations—the Cashea integration could drive platform growth and patient loyalty. The move also reflects a broader industry shift toward patient-centric financial solutions, potentially impacting how healthcare services are delivered and consumed in emerging economies.
